Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Intravenous (IV) Compounding Automation Market Forecast: Value Set To Climb From $2.45 Billion To $3.79 Billion
The intravenous (IV) compounding automation market size has seen substantial growth in recent years. This market is anticipated to expand from $2.19 billion in 2025 to $2.45 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.9%. The historical expansion of this market can be linked to the increased adoption of robotic compounding systems, a rising demand for chemotherapy automation, a greater emphasis on medication safety, the broadening of hospital and pharmacy automation, and enhanced awareness regarding workflow efficiency.
The intravenous (IV) compounding automation market is anticipated to experience significant expansion in the coming years. This market is projected to reach $3.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.6%. Factors driving this growth during the forecast period include greater investment in AI-driven compounding technologies, wider adoption of automated IV workstations, enhanced software integration with hospital information systems, broadened use of remote monitoring and predictive maintenance, and the progressive development of modular and customizable compounding systems. Key trends anticipated for the forecast period encompass breakthroughs in AI and machine learning for compounding, progress in robotic and automated devices, the evolution of smart pump and monitoring technologies, novel sterile compounding isolators and safety cabinets, and improvements in compact, space-efficient automation solutions.
Get A Free Sample Report With In-Depth Market Insights:
Intravenous (IV) Compounding Automation Market Development Factors: What’s Supporting Demand?
The increasing need for pharmaceutical goods is anticipated to fuel the expansion of the intravenous (IV) compounding automation market in the future. A pharmaceutical product refers to a substance or combination of substances designed for the diagnosis, treatment, prevention, or relief of diseases and medical conditions in humans or animals. IV compounding automation aids pharmaceutical products by facilitating the accurate, safe, and efficient preparation of intricate intravenous medications, ensuring precise dosages, mitigating contamination hazards, and enabling healthcare providers to satisfy the rising requirement for superior therapies. As an illustration, in November 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association, reported that the total pharmaceutical production in Europe reached €390,000 million ($422,803 million) in 2023, an increase from €363,300 million ($393,857 million) in 2022. Consequently, the escalating demand for pharmaceutical products is propelling the growth of the intravenous (IV) compounding automation market.
Intravenous (IV) Compounding Automation Market Segment Landscape And Growth Outlook
The intravenous (iv) compounding automation market covered in this report is segmented –
1) By Product Type: Robotic Compounding Systems, Automated Compounding Devices, Software Solutions, Other Product Types
2) By Service: Installation, Maintenance, Training, Consulting, Support, System Integration, Validation, Software Updates, Calibration, Remote Monitoring
3) By Application: Chemotherapy, Parenteral Nutrition, Antibiotics, Other Applications
4) By End-User: Hospitals, Compounding Pharmacies, Oncology Centers, Other End-Users
Subsegments:
1) By Robotic Compounding Systems: Robotic Arm Based Systems, Closed System Robotic Compounding Units, Hazardous Drug Handling Robots, Sterile Preparation Robotic Platforms
2) By Automated Compounding Devices: Volumetric Compounding Devices, Gravimetric Compounding Devices, Multi Chamber Compounding Units, Automated Parenteral Nutrition Compounding Devices
3) By Software Solutions: Compounding Workflow Management Software, Dose Verification Software, Barcode Based Medication Safety Software, Compounding Data Analytics And Reporting Software
4) By Other Product Types: Semi Automated Compounding Systems, Isolator Based Compounding Systems, Sterile Admixture Preparation Cabinets, Hybrid Compounding Assistance Devices
Intravenous (IV) Compounding Automation Market Key Players Shaping Industry Direction
Major companies operating in the intravenous (iv) compounding automation market are Becton Dickinson and Company, Baxter International Inc., Grifols S.A., ICU Medical Inc., Omnicell Inc., Fresenius Kabi AG, Equashield Medical Ltd., Health Robotics S.r.l., Loccioni Group, Loccioni Group, OPTIMA pharma GmbH, Medimix Systems AG, ARxIUM Inc., General Healthy Co. Ltd., PharmaScope Onco Automation B.V., Comecer SpA, Syntegon Technology GmbH, Parata Pharmacy Automation, B. Braun SE, Aesynt Incorporated, Shenzhen Broadcare Robots Co. Ltd.
View The Full Intravenous (IV) Compounding Automation Market Report:
Intravenous (IV) Compounding Automation Market Regional Analysis: Which Geography Leads On Revenue?
North America was the largest region in the intravenous (IV) compounding automation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous (iv) compounding automation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model